Table 3.
Univariable and multivariable associations between patient characteristics and continuing pre-conceptive selective serotonin reuptake inhibitor (SSRI) use during pregnancy. aOR = adjusted odds ratio, CI = confidence interval
| Univariable outcome | Multivariable outcome | |||
|---|---|---|---|---|
| cOR (95%CI) | p value | aOR (95%CI) | p value | |
| Year of delivery | 1.10 (1.08–1.12) | < 0.01 | 1.10 (1.08–1.11) | < 0.01 |
| Parity | 1.15 (1.09–1.22) | < 0.01 | 1.15 (1.09–1.21) | < 0.01 |
| Socio-economic status | ||||
| Low | 0.86 (0.75–0.98) | 0.03 | 0.87 (0.75–1.00) | 0.05 |
| High | 0.99 (0.87–1.13) | 0.88 | 0.97 (0.84–1.11) | 0.64 |
| Concomitant use of psycholeptics | 0.47 (0.42–0.53) | < 0.01 | 0.50 (0.43–0.55) | < 0.01 |
| Number of co-medications | 0.98 (0.96–1.00) | 0.03 | 1.00 (0.98–1.02) | 0.92 |